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ABSTRACT 
A critical barrier to future implementation of regenerative treatments for sensorineural hearing 
loss is the lack of diagnostic tools that can specify the target(s) within the cochlea and auditory nerve for 
delivery of therapeutic agents.  This study used a gerbil model to test the idea of mapping auditory nerve 
firing density by tracking the amplitude of high-level compound action potentials (CAPs) while varying 
the bandwidth of simultaneous masking noise.  The distributions of neural firing, obtained by calculating 
the derivative of the equation describing CAP amplitude growth as a function of distance along the 
cochlea, indicated that high-level chirp stimuli trigger widespread neural firing in the cochlea that is 
unaltered by sensory outer hair cell pathology.  These results suggest that CAP-derived neural density 
functions for high-level chirp stimuli may provide reliable maps of auditory nerve density in impaired 
ears. 
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INTRODUCTION 
Prompt diagnosis and treatment of hearing loss can avert delays in speech and language 
acquisition in children (Yoshinaga-Itano et al., 1998; Moeller, 2000; Cunningham and Cox, 2003) and 
social isolation in adults (Monzani et al., 2008; Poissant et al., 2008).  The development of objective 
diagnostic tools such as auditory evoked potentials (AEPs) and otoacoustic emissions (OAEs) has 
significantly reduced the age of identification of hearing loss in children (Cone-Wesson et al., 2000) and 
enhanced differentiation of the sensory and neural components of sensorineural hearing loss.  Advances 
in hearing aid and cochlear implant technology have resulted in modest improvements in word 
recognition performance (Koch, 2004; Bentler et al., 2006; Firszt, 2009), listening comfort in noise 
(Chung et al., 2006; Bentler et al., 2008), and patient satisfaction (Kochkin, 2007; Ou et al., 2008).  Yet 
benefit from even the most advanced technology can vary considerably across patients with similar 
audiometric profiles suggesting differences in the underlying pathology that are not apparent in routine 
clinical measures of hearing impairment.  Advanced diagnostic techniques that can pinpoint the cochlear 
location of hair cell loss and neural degeneration may improve individualization of gain prescriptions for 
hearing aids and offer guidance for optimal electrode positioning (Briaire and Frijns, 2006) and mapping 
strategies for cochlear implant recipients (Bierer and Faulkner, 2010).  Such precise diagnostic tools 
would also seem to be crucial if cochlear hair cell regeneration (e.g., Edge and Chen, 2008) and auditory 
nerve regeneration (e.g., Matsuoka et al., 2007; Agterberg et al., 2009) eventually become viable 
treatment options for individuals with sensorineural hearing loss. 
Since OAEs and short-latency AEPs reflect cochlear outer hair cell (OHC) and auditory nerve 
function, respectively, they likely offer the best non-invasive glimpse of peripheral pathophysiology 
contributing to sensorineural hearing loss.  Presence or absence of OAEs and threshold and latency of 
AEPs are the parameters routinely analyzed in the clinic.  However, analysis of other response parameters 
such as amplitude, response area, and morphology may expand the diagnostic utility of these measures.  
For example, Don et al. (2005) demonstrated that their stacked auditory brainstem response (ABR) 
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technique, which optimizes wave V amplitude by temporally aligning and summing derived-band ABRs, 
detects the presence of small acoustic neuromas with 95% sensitivity and 88% specificity.  Ferraro and 
Durrant’s (2006) method of calculating the area ratio between the summating potential (SP) and the 
action potential (AP) portions of electrocochleography waveforms achieves 92% sensitivity and 84% 
specificity in diagnosing Ménière’s disease/endolymphatic hydrops (Al-momani et al., 2009).  Other 
studies in the cochlear implant literature have indicated that the amplitude of electrically evoked auditory 
potentials is positively correlated with the number of viable auditory neurons (Smith and Simmons, 1983; 
Hall, 1990) and may predict prognosis for implant recipients (Gibson and Sanli, 2007; Teagle et al., 
2010).  
Chertoff (2004) and Chertoff et al. (2008) used a gerbil model to investigate the utility of the 
compound action potential (CAP) in identifying auditory nerve fiber degeneration.  Their approach was to 
quantify the morphology of CAPs by fitting the waveforms with a five-parameter convolution model 
adapted from Goldstein and Kiang (1958).  One of the model parameters (N) scales the magnitude of the 
N1 portion of the CAP similar to conventional measures of N1 amplitude (i.e., baseline to N1 peak) and 
theoretically represents the number of nerve fibers contributing to the recorded response.  Earl and 
Chertoff (2010) tested this theory by using the convolution model to fit CAPs evoked with tonebursts (1-
16 kHz) in gerbils with partial lesions of the auditory nerve.  At high stimulus levels (100 dB SPL for 1-8 
kHz, 75 dB SPL for 16 kHz), the model parameter N and conventional measures of N1 amplitude were 
positively correlated with the percentage of surviving nerve fibers within the whole nerve bundle.  
Although the measures of N1 magnitude of high-level CAPs appeared to predict overall auditory nerve 
survival, the magnitude values at different stimulus frequencies did not pinpoint the corresponding 
frequency region of the cochlea where neural damage was located. 
A location-specific estimate of neural damage may be possible by systematically limiting the 
region of nerve fibers contributing to high-level CAPs with a high-pass noise masking paradigm (e.g., 
Bone et al., 1972; Shore and Nuttall, 1985; see Literature Review in Appendix A).  The schematic of an 
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uncoiled cochlea and the accompanying plots in Figure 1 illustrate the theory behind the idea.  A high-
level stimulus that triggers synchronous neural excitation along the majority of the cochlea is used to 
evoke CAPs while the high-pass cutoff frequency of simultaneous masking noise is stepped from low 
frequencies encoded in the apex to high frequencies encoded in the base.  In a normal cochlea with a full 
complement of nerve fibers, normalized N1 amplitude accumulates in a sigmoid manner as progressively 
more neurons are allowed to contribute to the CAP (solid line in Figure 1, bottom left panel).  Plotting the 
derivative of the cumulative amplitude function yields a neural density function that is assumed to 
represent the spread of neural firing generated in the cochlea by a given stimulus (solid line in Figure 1, 
bottom right panel).  In a cochlea with a gap of missing auditory nerve fibers (dashed line in Figure 1, 
bottom left panel), normalized N1 amplitude would increase faster than normal until the masker cutoff 
frequency moves into the region of missing nerve fibers.  Since there are no additional nerve fibers to 
contribute to the CAP, the amplitude function would plateau until the masker moves more basally to the 
location where nerve fibers are present.  The neural density function for the cochlea with missing fibers 
(dashed line in Figure 1, bottom right panel) would show a drop in neural firing density that is assumed to 
identify the distance along the basilar membrane where neurons are nonfunctional or absent (Figure 1, 
bottom right panel). 
The long-term goal of this research is to test the theory that CAP-derived neural density functions 
can predict the corresponding cochlear location of auditory nerve degeneration in impaired ears.  The 
objective of this study was to use the high-pass masking technique to answer the following two questions 
that are pertinent to achieving the long-term goal:  
1. What is the ideal acoustic stimulus for evoking synchronous neural firing along the majority 
of the cochlea? 
2. Does OHC pathology alter high-level neural density functions? 
To answer the first question, two types of acoustic stimuli were considered.  According to the 
traveling wave theory, a high-level low frequency toneburst may be ideal because it triggers substantial 
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basilar membrane displacement from the base of the cochlea to the characteristic low frequency place in 
the apex (Eggermont, 1976).  A rising frequency toneburst (i.e., chirp) may be more ideal than a low 
frequency toneburst because the high frequency components of a chirp are delayed relative to the low 
frequency components which compensates for the cochlear traveling wave delay.  This temporal 
compensation theoretically leads to simultaneous displacement and synchronous neural firing along the 
majority of the basilar membrane (Shore and Nuttall, 1985; see Literature Review in Appendix A). 
The findings of several studies on the influence of stimulus level on cochlear mechanics suggest 
the answer to the second question.  Specifically, the findings of Dallos and Harris (1978), Ruggero and 
Rich (1991), and Fridberger et al. (2002) indicate that OHCs act primarily to enhance basilar membrane 
displacement for low to moderate-level inputs.  High-level inputs (e.g., 90 dB SPL) are assumed to trigger 
sufficient basilar membrane displacement to stimulate the inner hair cells (IHCs) directly.  Therefore, any 
changes in high-level neural density functions would not be related to OHC pathology but would reflect 
the status of the primary afferent neurons that synapse with IHCs.  Neural density functions for moderate-
level stimuli (e.g., 60 dB SPL) would be expected to be influenced by OHC pathology. 
Consideration of these theories and experimental observations led to the formulation of the 
following hypotheses for this study: 
1. High-level chirps trigger a broader spread of synchronous neural firing along the cochlear 
partition than high-level low frequency tonebursts. 
2. OHC pathology does not alter high-level neural density functions. 
The first hypothesis was tested in normal-hearing gerbils (Experiment 1) by comparing neural density 
functions obtained for chirps and for 2 kHz (relatively low frequency for gerbil) tonebursts.  The second 
hypothesis was tested in an additional experiment (Experiment 2) by comparing neural density functions 
obtained from gentamicin-exposed gerbils to those obtained from normal-hearing gerbils in Experiment 1. 
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Materials and Methods 
Animal Preparation 
Young-adult Mongolian gerbils (Meriones unguiculates), weighing between 45 and 70 grams, 
were used for this study.  A gerbil model is ideal because their low frequency hearing sensitivity is similar 
to that of the human auditory system and due to the ease of the surgical approach to the cochlea.  Prior to 
surgery, all animals were sedated with an initial intraperitoneal injection of pentobarbital (64 mg/kg).  
Supplementary intramuscular injections of pentobarbital (~30 mg/kg) were given hourly to maintain 
appropriate sedation throughout the surgery and data collection.  Animals were placed in the supine 
position and wrapped in a warming pad to maintain body temperature at 37
o
 C.  Following local injection 
of lidocaine, a 10-15 mm post-auricular incision was made and the underlying neck musculature was 
dissected to access the right middle ear cavity (bulla).  The bulla was opened with surgical tweezers to 
allow for placement of an electrode in the round window niche for CAP recordings (Experiments 1 and 2) 
and delivery of gentamicin solution to the niche to induce OHC impairment (Experiment 2).  All 
experimental procedures were approved by the Institutional Animal Care and Use Committee of the 
University of Kansas Medical Center. 
Generation of CAP Stimuli and Masking Noise 
A gerbil-tailored chirp stimulus and a traditional 2 kHz toneburst stimulus were generated for this 
study.  The chirp stimulus (Fig. 2, left panel) was tailored to gerbil by sweeping the frequency from 1 to 
60 kHz, nearly the entire frequency range of gerbil hearing, at a rate that coincides with the inverse of an 
estimate of cochlear traveling wave delay in gerbil (Fig.2, middle panel).  The cochlear traveling wave 
delay was estimated by fitting gerbil CAP latency data for toneburst stimuli between 1 and 16 kHz at 5 
dB above threshold (Earl and Chertofff, 2010) with the following equation: 
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where t(f) is cochlear traveling wave delay in seconds (s),  f is stimulus frequency in Hz, and the constants 
c and α are 0.01415 and -0.1960, respectively.  Using these constants and equations 3-6 of Fobel and Dau 
(2004), the chirp waveform was generated in Matlab (MathWorks, Natick, MA) using a time resolution of 
4 µs (i.e., sampling frequency = 250 kHz).  Ramping up the amplitude of the chirp stimulus (Fig. 2, left 
panel) as the instantaneous frequency increased, according to the amplitude scaling factor (Eq. 7) of Fobel 
and Dau (2004), produced a chirp with relatively flat spectral magnitude between 1 and 60 kHz (Fig. 2, 
right panel).  Chirp stimuli were presented with alternating polarity at a rate of 25/s. 
A traditional 2 kHz toneburst stimulus was generated with 1 ms rise/fall times and an 8 ms 
plateau.  A relatively long-duration toneburst (e.g., 10 ms) was chosen to facilitate differentiation of the 
N1 and SP components of the CAP.  Tonebursts were delivered with alternating polarity, to minimize the 
cochlear microphonic (CM), at a rate of 40/s. 
Broadband white noise was generated (D/A sampling rate = 97.7 kHz) and high-pass filtered with 
fifth order Butterworth filters (slopes ≥ 80 dB per octave) using signal processing software (RPvdsEx) 
and a Real-time Processor (RP2) from Tucker-Davis Technologies (TDT; Alachua, FL, USA).  Multiple 
high-pass cutoff frequencies were chosen to correspond to 0.25 mm increments along the first 3 mm of 
the base of the gerbil cochlea where the best frequency ranges from 53.4 kHz to 13.8 kHz.  For the middle 
through apical regions of the gerbil cochlea (3-11 mm), where the best frequency ranges from 13.2 kHz to 
360 Hz, cutoff frequencies were chosen to correspond to 0.5 mm increments.  The lowest cutoff 
frequency was 400 Hz and the highest cutoff frequency was 45987 Hz making a total of 25 masking 
conditions.  Since the spectral energy of white noise decreases as the spectral bandwidth decreases (i.e., 
high-pass cutoff frequency increases), the root-mean-square (RMS) SPL of the partial-bandwidth masking 
conditions were equated to the RMS SPL of the full-bandwidth masking condition (0.4-50 kHz).  
Otherwise, changes in spectral energy of the noise across masking conditions could confound the 
interpretation of CAP amplitude changes. 
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The masking signal was added to the CAP stimulus (i.e., chirp or 2 kHz toneburst) with a signal 
mixer (SM5, TDT) and delivered via a magnetic loudspeaker (FF1, TDT) with a relatively flat (+/- 8 dB) 
frequency response from 1 to 50 kHz.  Electromagnetic artifact from the loudspeaker was minimized to 
negligible levels by housing the loudspeaker in a custom-made mu metal case (MµShield; Manchester, 
NH, USA) and by positioning it 15 cm away from the opening of the animals’ ear canals.  A 1/8” Brüel & 
Kjaer (Denmark) microphone (B&K 4138) was suspended within 5 mm and at a 90 degree azimuth 
relative to the ear canal opening and diaphragm of the loudspeaker.  The reported frequency sensitivity of 
the B&K microphone is essentially flat (+/- 2 dB) from 0.02 to 100 kHz when it is positioned at a 90 
degree azimuth relative to the sound source.  The microphone output was routed to an oscilloscope and a 
spectrum analyzer; the oscilloscope (Tektronix, TDS 2014) to calibrate the peak SPL (pSPL) of the CAP 
stimulus (i.e., chirp or 2 kHz toneburst), and the spectrum analyzer (Hewlett Packard, 3561A) to verify 
the spectral bandwidth of each masking condition. 
CAP Recordings 
 CAPs were recorded using a silver ball electrode on the round window and a ground electrode in 
the contralateral shoulder musculature.  An absorbent cotton wick (Densply Maillefer, Tulsa, OK) was 
placed next to the round-window electrode and subsequently changed every 15 minutes to control fluid 
build-up in the niche.  The electrophysiologic signals were amplified by a factor of 5000, band-pass 
filtered (0.03- 6 kHz) by two amplifiers/filters in series (Stanford Research Systems SR560, Sunnyvale, 
CA, USA; Stewart Electronics VBF10, Lyman, SC, USA), and digitized at 250 kHz by an analog to 
digital converter (AD2, TDT) before being averaged within a 15 ms time window.  The raw CAP 
waveforms were named according to stimulus type, stimulus level, and high-pass cutoff frequency, and 
then saved to disk after sufficient averages were obtained to achieve an adequate signal to noise ratio. 
Procedures 
In Experiment 1, data were collected from a group of normal-hearing gerbils (n=9) to compare 
neural density functions for chirps and 2 kHz tonebursts at a high level (90 dB pSPL) and at a moderate 
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level (60 dB pSPL).  Animals were considered to have normal hearing sensitivity if their CAP threshold 
for chirps was ≤ 20 dB pSPL.  N1 amplitude growth data was obtained for the four stimulus conditions in 
the following order: chirps at 60 dB pSPL, 2 kHz tonebursts at 60 dB pSPL, chirps at 90 dB pSPL, and 2 
kHz tonebursts at 90 dB pSPL.  Each recording condition began by measuring the amplitude of N1 
(baseline to negative peak of N1 as demonstrated in Fig. 3, left panel) of the unmasked CAP on a digital 
oscilloscope (Tektronix TDS 2014).  The full-bandwidth masker (0.4-50 kHz) was then presented and 
attenuated to a level that reduced the amplitude of N1 by 80% similar to the procedure of Eggermont 
(1977).  The bandwidth of the white noise was subsequently varied by changing the high-pass cutoff 
frequency and CAPs were recorded for each of the 25 masking conditions.  The sequence of masking 
conditions was randomized and interspersed with two recordings of unmasked CAPs.  A fourth unmasked 
CAP was recorded after all masking conditions were presented.  Representative unmasked and masked 
CAPs for six different stimulus conditions are presented in Appendix C.  The average time required to 
record the 29 CAPs for one stimulus condition was 27 minutes while the average duration of the entire 
protocol of Experiment 1 was just over 2 hours.  The CAP threshold for chirps was measured again at the 
completion of the protocol to determine if the multiple presentations of masking noise led to an elevation 
in threshold. 
In Experiment 2, data were collected from a group of gentamicin-exposed gerbils (n=10) to 
compare neural density functions obtained from animals with impaired OHCs to the neural density 
functions obtained from the normal-hearing gerbils in Experiment 1.  Gentamicin, an aminoglycoside 
antibiotic, was chosen for this study based on data from several studies indicating that OHCs are more 
prone to gentamicin ototoxicity than are IHCs (e.g., Wanamaker et al., 1998; Heydt et al., 2004; see 
Literature Review in Appendix A).  The chosen dosage of gentamicin (200 µg applied directly to round 
window) was based on data for mice (Heydt et al., 2004) and gerbils (Wanamaker et al., 1998; Sheppard 
et al., 2004; Suryadevara et al., 2009) showing that similar dosages led to OHC pathology across the base 
to middle regions of the cochlea.  A 200 µg/µl gentamicin solution was prepared by dissolving 
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gentamicin sulfate powder (Sigma; St. Louis, MO, USA) in distilled water after the manner described by 
Husmann et al. (1998).  Specifically, to achieve a 200 µg/µl (i.e., 200 mg/ml) concentration of gentamicin 
in solution, 313 mg of gentamicin sulfate powder, containing 0.639 mg of gentamicin per mg, was 
dissolved in 1 ml of distilled water.   
Prior to gentamicin exposure, baseline CAP thresholds were determined for chirps and toneburst 
stimuli at 2, 4, 8, 16, and 32 kHz.  The amplitude of the cochlear microphonic (CM) to a 16 kHz toneburst 
(10 ms duration) at 80 dB pSPL was also measured prior to gentamicin delivery and then monitored 
during the exposure period to gauge the effect of gentamicin on OHC function.  The CM recordings were 
acquired with the same electrode montage, recording parameters, and instrumentation set-up as the CAP 
recordings with one exception: the low-pass filter setting was changed from 6 kHz to 25 kHz to capture 
the CM to the 16 kHz tone.  A high frequency tone (e.g., 16 kHz) was chosen for CM monitoring under 
the assumption that it would provide an early indication of OHC impairment resulting from the diffusion 
of gentamicin through the round window membrane and into the basal region (i.e., high frequency region) 
of the cochlea (Wanamaker et al., 1998).  Without removing the recording electrode, 1 µl of the 200 µg/µl 
gentamicin solution was applied directly to the round window niche.  The amplitude of the CM was 
monitored 1 minute post-gentamicin application and then in 5-minute increments until the CM amplitude 
had dropped by at least 50% (relative to the pre-gentamicin amplitude) and at least 15 minutes had 
elapsed.  The gentamicin solution was then removed from the niche with an absorbent cotton wick and the 
CAP threshold to chirps was measured again.  If the chirp CAP threshold had increased by at least 10 dB, 
the experiment proceeded with post-gentamicin measures of N1 amplitude growth for chirps at 60 dB 
pSPL and then for chirps at 90 dB pSPL using the same masking procedures described above.  Masked 
CAPs were not recorded for 2 kHz tonebursts at 60 or 90 dB pSPL per the results of Experiment 1 (see 
below).  The chirp CAP threshold and toneburst CAP thresholds were measured again following the 
completion of both stimulus conditions.  The average time required for one stimulus condition in 
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(2) 
Experiment 2 was 23 minutes and the average duration of the entire masked CAP protocol was 52 
minutes. 
Data Analysis 
Manual measures of N1 peak amplitude (baseline to N1 peak) and N1 peak latency for all stimulus 
conditions of both experiments were completed offline in Matlab following data collection.  The left 
panel of Figure 3 displays representative unmasked and masked CAPs indicating the trend, observed in 
this and other studies (e.g. Teas et al., 1962; Shore and Nuttall, 1985), of decreasing N1 amplitude and 
increasing N1 latency as high-pass masker cutoff frequency decreases.  The raw amplitude values (filled 
circles, Fig. 3, right panel) were normalized relative to the average unmasked amplitude to allow for 
amplitude growth comparisons across stimulus types and levels.  The raw latency values (open circles, 
Fig. 3, right panel) were also normalized by calculating the shift in latency by subtracting the average 
unmasked latency from the masked latency. 
Figure 4 demonstrates the data-fitting procedure (left panel) and the two dependent variables used 
for statistical analyses (right panel).  First, normalized N1 amplitude values for the masked CAPs were 
plotted as a function of distance from apex in mm (Fig. 4, left panel).  The high-pass cutoff frequencies 
(as shown on the abscissa in Fig. 3, right panel) were converted to distance from apex in mm (as shown 
on the abscissa in Fig. 4, left panel) using the frequency-place map for gerbil cochleae from Müller 
(1996).  The cumulative amplitude function (CAF; thick curve in Fig. 4, left panel) was obtained for each 
stimulus condition by using SigmaPlot (Systat Software, Inc., San Jose, CA, USA) to fit the normalized 
N1 amplitude data with the following four-parameter sigmoid function: 
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(3) 
where a scales the inflection point of N1 amplitude growth, b governs the rate of amplitude growth, x0 is 
the distance from apex (mm) where inflection of amplitude growth occurs, and y0 defines the starting 
amplitude reduction relative to the unmasked amplitude.  The parameter y0 is a constant in terms of Eq. 2 
and in the design of the masking paradigm since the target level for the initial masked condition was 20% 
of the unmasked amplitude.  The neural density function (NDF; thick curve in Fig. 4, right panel) was 
obtained for each stimulus condition by using the CAF parameters to solve the analytical derivative of Eq. 
2 for distance from apex (x) which is: 
 
 
 
 
where a and b proportionally scale the peak density and bandwidth, respectively, and x0 is the peak 
location in distance from apex (mm). 
The theoretical foundation for constructing NDFs by taking the derivative of CAFs is based on 
the relationship between two functions that are pertinent to probability theory: the cumulative distribution 
function and the probability density function (Feller, 1968).  The cumulative distribution function is an s-
shaped curve spanning negative to positive values across the x-axis as it grows steadily from 0 to 1 on the 
y-axis.  Plotting the derivative of the cumulative distribution function yields the probability density 
function, a bell-shaped curve spanning the same negative to positive values across the x-axis and peaking 
on the y-axis where x = 0.  The N1 amplitude growth functions that were generated with the high-pass 
masking paradigm in this study are not only similar in appearance to the s-shaped cumulative distribution 
function but are also similar in construction.  In other words, the N1 amplitude growth function represents 
an accumulation of amplitude as progressively more neurons are allowed to synchronously contribute to 
the CAP as the cochlear spread of the masker decreases.  Given this foundation and amplitude growth 
functions with 25-point resolution, it seems reasonable to use sigmoid functions (of similar form as the 
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cumulative distribution function) to fit the amplitude data and take the analytical derivative of that 
equation (i.e., CAF) to construct the NDF. 
The two dependent variables chosen for statistical analysis (SPSS 17.0) were NDF bandwidth and 
NDF peak location.  NDF bandwidth quantifies the cochlear spread of synchronous neural firing and NDF 
peak location identifies the location along the cochlear partition where neural firing density peaks.  NDF 
bandwidth was defined as the distance spanned by the inner 2/3 of the area under the NDF curve and was 
calculated by multiplying the peak density of the NDF by 0.3413 and finding the difference between the 
corresponding values for distance from apex.  NDF peak location was given by the value of parameter x0.  
Paired samples t-tests were used to compare bandwidth and peak location across stimulus type at 60 and 
90 dB pSPL in Experiment 1.  Independent samples t-tests were used to compare bandwidth and peak 
location of chirp-generated NDFs across the normal-hearing and gentamicin-exposed groups in 
Experiment 2. 
 
RESULTS 
The presentation of results will focus on NDF bandwidth and NDF peak location as the two 
primary dependent measures of neural firing density across stimulus types in Experiment 1 and across 
normal-hearing and gentamicin-exposed groups in Experiment 2.  However, data for unmasked CAP 
amplitudes are presented at the outset to demonstrate the effectiveness of chirps as stimuli for evoking 
CAPs.  N1 latency data for both experiments were not analyzed in depth for this study but are shown in 
Figures D.1 and D.2 of Appendix D.   
Unmasked CAP Amplitudes 
Representative CAPs evoked in normal-hearing gerbils with 2 kHz tonebursts and chirps at 60 dB 
pSPL are shown in the top panel of Figure 5.  In addition to being nearly 10 times larger in magnitude 
than the 2 kHz toneburst CAP (Fig. 5, top left panel), the chirp CAP (Fig. 5, top right panel) has narrower 
N1 morphology.  Comparing the unmasked N1 amplitudes across stimulus type and stimulus level (Fig. 5, 
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bottom panel) indicates that chirps at 60 dB pSPL produced the largest CAPs and 2 kHz tonebursts at 60 
dB pSPL produced the smallest CAPs.  Interestingly, chirps at 30 dB pSPL generated larger CAPs than 2 
kHz tonebursts at 90 dB pSPL.  Calculating the coefficients of variation (CV, standard deviation/mean) of 
the unmasked amplitude data revealed that the amplitude measures for chirps at 60 dB pSPL were the 
least variable (CV = 0.16) and the amplitude measures for 2 kHz tonebursts at 90 dB pSPL were the most 
variable (CV = 0.32) across animals.  The CVs of the other stimulus conditions were 0.24, 0.24, and 0.27, 
for 2 kHz tonebursts at 60 dB pSPL, chirps at 90 dB pSPL, and chirps at 30 dB pSPL, respectively. 
To determine the variability of the unmasked amplitude measures within animals, which served 
as the reference for normalization of the masked amplitude values, the within-animal CVs of the 
unmasked amplitudes were also calculated for the four stimulus conditions of Experiment 1 and the two 
stimulus conditions of Experiment 2.  The highest within-animal CV of 0.22 was observed for the 
unmasked amplitudes of CAPs to chirps at 90 dB pSPL from a normal-hearing gerbil.  The lowest within-
animal CV of 0.01 was noted for the unmasked amplitudes of CAPs to chirps at 60 dB pSPL, also from a 
normal-hearing gerbil.  The mean within-animal CV for unmasked amplitude across stimulus conditions 
for the normal-hearing group were 0.11, 0.04, 0.06, and 0.08, for CAPs to chirps at 90 dB pSPL, chirps at 
60 dB pSPL, 2 kHz tonebursts at 90 dB pSPL, and 2 kHz tonebursts at 60 dB pSPL, respectively.  For the 
gentamicin-exposed group, the mean within-animal CV for unmasked amplitudes was 0.11 for chirps at 
90 dB pSPL and 0.10 for chirps at 60 dB pSPL. 
Experiment 1: Cumulative Amplitude Functions (CAFs) 
Figure 6 shows the normalized N1 amplitude growth data (thin lines) for the nine normal-hearing 
gerbils in Experiment 1 with the mean of their respective CAFs (thick lines) for chirps and 2 kHz 
tonebursts at 90 dB pSPL and 60 dB pSPL.  The variance of the data across animals and across conditions 
was largest for 2 kHz tonebursts at 60 dB pSPL and smallest for chirps at 60 dB pSPL.  The mean CAF 
for chirps at 90 dB pSPL grows gradually and just begins to saturate near the base (i.e., 11 mm from 
apex).  In contrast, the mean CAF for 2 kHz tonebursts at 90 dB pSPL rises quickly and saturates by 
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approximately 9 mm from the apex.  The CAF for chirps at 60 dB pSPL is similar to the pattern observed 
for 2 kHz tonebursts at 90 dB pSPL whereas the CAF for 2 kHz tonebursts at 60 dB pSPL begins to grow 
close to the apex and saturates approximately 7 mm from the apex.  The N1 amplitude function depicted 
with the dashed thin line in the upper right panel (2 kHz toneburst – 90 dB pSPL) was determined to be 
an outlier and was excluded from statistical analysis because its initial masked amplitude was more than 
two standard deviations (SD) above the mean of the initial masked amplitude across all amplitude 
functions in Experiment 1.  The mean coefficients of determination (R
2
) indicate that the four-parameter 
sigmoid function accounts for a large majority of the variance in the N1 amplitude data for all four 
stimulus conditions.  The assumptions of normality and constant variance were satisfied for all CAFs for 
all four stimulus conditions with one exception: the assumption of constant variance was violated for one 
CAF for chirps at 90 dB pSPL. 
Experiment 1: Neural Density Functions (NDFs) 
Figure 7 displays individual NDFs (thin lines) with their corresponding mean NDFs (heavy lines) 
for each of the four stimulus conditions.  The NDFs illustrate, as did the CDFs, that the variance across 
animals was largest for 2 kHz tonebursts at 60 dB pSPL and smallest for chirps at 60 dB pSPL.  The 
individual NDF shown with the dashed line in the upper right panel (2 kHz toneburst – 90 dB pSPL) 
represents the outlier that was described previously in Figure 6. 
Figure 8 illustrates the differences in mean NDF bandwidth and mean NDF peak location for 
chirps (solid lines) and 2 kHz tonebursts (dashed lines) at 90 and 60 dB pSPL.   At 90 dB pSPL (Fig. 8, 
left panel), the mean NDF for chirps was significantly broader (p = 0.04) and peaked significantly closer 
to the base (p = 0.001) than the mean NDF for 2 kHz tonebursts.  At 60 dB pSPL (Fig. 8, right panel), the 
mean NDF for 2 kHz tonebursts was significantly broader than the mean NDF for chirps (p = 0.04) 
although the mean NDF for chirps peaked significantly closer to the base (p < 0.001).  Table 1 
summarizes the descriptive statistics and the results of the paired samples t-tests used to compare the 
mean of the paired differences for the two variables across stimulus type at both levels.  The assumption 
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of normality was satisfied by the values for NDF bandwidth and NDF peak location for all four stimulus 
conditions in Experiment 1 per Shapiro-Wilk’s test of normality.   
Experiment 2: Gentamicin-Induced Changes in CM Amplitude and CAP Threshold 
The left panel of Figure 9 illustrates that the amplitude of the CM, evoked with 16 kHz tones at 
80 dB pSPL, decreased exponentially over a course of minutes following application of 200 µg of 
gentamicin to the round window niche.  Dose-response curves for gentamicin doses of 50 and 100 µg are 
shown for comparison.  All 10 of the animals included in Experiment 2 experienced at least a 50% 
reduction in CM amplitude after an exposure to 200 µg of gentamicin lasting at least 15 minutes. 
The right panel of Figure 9 shows post-gentamicin shifts in CAP thresholds for chirps (measured 
after removal of gentamicin from the niche) and toneburst stimuli (measured after completion of post-
gentamicin masked CAP conditions).  Shifts in chirp CAP thresholds ranged from 10 to 25 dB while 
shifts in toneburst CAP thresholds generally increased as stimulus frequency increased.  Comparing the 
post-gentamicin measures of chirp CAP threshold to the measures of chirp CAP threshold at the 
completion of the post-gentamicin masked CAP conditions revealed that the largest within-animal 
fluctuation was 10 dB and the group mean fluctuation was less than 5 dB, indicating that threshold shifts 
were generally stable after exposure to gentamicin and multiple presentations of masking noise.   
However, progressive elevations in CAP thresholds and steady decline in unmasked CAP 
amplitudes following gentamicin exposure were observed in two animal experiments that began with 
chirps at 90 dB pSPL.  Both experiments were terminated prematurely and a synergistic effect of 
gentamicin plus noise exposure (see Literature Review in Appendix A) was suspected due to the high 
levels of noise that were required to achieve the initial 80% reduction in amplitude of the high-level 
CAPs.  Progressive CAP threshold elevation and declining CAP amplitude were observed in one other 
animal experiment that started with CAPs to chirps at 60 dB pSPL and consequently lower levels of 
masking noise. 
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Experiment 2: CAF & NDF Comparisons across Groups 
The top panels of Figure 10 compare the individual data and mean CAFs for chirps of the post-
gentamicin group to normal ranges constructed with the data from Experiment 1.  At 90 dB pSPL, the 
individual N1 amplitude functions of the 10 gentamicin-exposed gerbils (top left panel, thin lines) fell 
essentially within the normal range (mean of N1 amplitude +/- 2SD; gray area).  In contrast, at 60 dB 
pSPL a large portion of the functions for 6 out of the 10 gentamicin-exposed animals (top right panel, thin 
lines) fell outside the normal range.  The mean post-gentamicin CAF at 60 dB pSPL (thick dashed line, 
top right panel) grows at a similar rate as the normal range; however, the post-gentamicin CAF is shifted 
nearly 1 mm closer to the apex than the normal range.  The mean R
2
 values for the CAF fits of the post-
gentamicin data (0.93 for chirps at 90 dB pSPL and 0.96 for chirps at 60 dB pSPL, respectively) suggest 
that the sigmoid function accounts for a large majority of the variance in the N1 amplitude data for both 
stimulus conditions.  The assumptions of normality and constant variance were satisfied for all CAFs for 
both stimulus conditions with two exceptions: the assumption of constant variance was violated for two 
CAFs for chirps at 60 dB pSPL. 
The bottom panels of Figure 10 compare the individual and mean post-gentamicin NDFs to the 
normal NDF ranges (mean +/- 2SD; gray areas) established with the data from Experiment 1.  Similar to 
the N1 amplitude plots in the upper panels, the NDFs of the two groups essentially overlap for chirps at 90 
dB pSPL (bottom left panel), whereas for chirps at 60 dB pSPL (bottom right panel), the distributions of 
the two groups appear to differ.  Table 2 summarizes the descriptive statistics and results of the 
independent samples t-tests (SPSS 17.0) of the difference across groups for mean bandwidth and mean 
peak location.  As hypothesized, there was not a significant difference between groups for mean NDF 
bandwidth or mean NDF peak location for chirps at 90 dB pSPL.  For chirps at 60 dB pSPL, mean NDF 
bandwidth was not significantly different across groups; however, the mean NDF peak location for the 
gentamicin-exposed group was significantly closer (p = 0.01) to the apex than the mean NDF peak 
location for the normal-hearing group (open circle).  As noted in Table 2 and illustrated in Figure 10, the 
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assumption of equal variance was violated for the NDF peak location data for chirps at 60 dB pSPL.  The 
assumption of equal variance was satisfied for the NDF bandwidth data for chirps at 60 dB pSPL and for 
the NDF bandwidth and peak location data for chirps at 90 dB pSPL.  The assumption of normality was 
satisfied for the NDF bandwidth and NDF peak location data for both chirp conditions of both groups 
(i.e., normal and post-gentamicin) according to the Shapiro-Wilk test of normality (SPSS 17.0). 
Experiment 2: Variability in NDF Peak Location 
To determine the possible contributors to the large variability observed in the NDF peak location 
for chirps at 60 dB pSPL, several scatter plots were constructed and correlation analyses were performed.  
Figure 11 illustrates a significant negative correlation (r = -0.74;  p = 0.003) between the post-gentamicin 
shift in NDF peak location for chirps at 60 dB pSPL and the post-gentamicin shift in chirp CAP 
thresholds.  The shift in NDF peak location was determined by calculating the differences between the 
individual post-gentamicin peak locations and the mean NDF peak location of the normal-hearing group 
for chirps at 60 dB pSPL.  The individual shifts in chirp CAP threshold were determined by calculating 
the difference between the pre-exposure threshold and the post-exposure threshold (measured 
immediately following the 15-minute gentamicin-exposure period).  Filled circles (n = 10) represent the 
animals that met the inclusion criteria for Experiment 2.  Open circles (n = 4) represent animals that were 
excluded from analysis due to progressive CAP threshold shifts during the course of data collection (two 
upper circles) or due to minimal chirp CAP threshold shifts or insufficient reduction in CM amplitude 
following gentamicin application (two lower circles).  Other scatter plots between the shift in NDF peak 
location for chirps at 60 dB pSPL and other post-gentamicin measures including toneburst CAP threshold 
shift and CM amplitude reduction did not reveal any significant correlations.   
 
DISCUSSION 
The motives for this study were to determine if high-level chirps trigger a broader spread of 
synchronous neural firing along the cochlear partition than high-level low frequency tonebursts and to 
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determine if high-level NDFs are unaltered by OHC pathology.  The results support both central 
hypotheses and provide additional data suggesting that NDFs constructed with chirps at a moderate level 
(i.e., 60 dB pSPL) are influenced by OHC pathology.  Other observations relating to chirp CAP 
amplitude, CAP latency shifts, the design of the chirp stimulus, the high-pass masking paradigm, and the 
data-fitting procedure have implications for future research and clinical application. 
Experiment 1: NDF Differences across Stimulus Type 
The results of Experiment 1 showing broader NDF bandwidths for high-level chirps than for 
high-level low frequency tonebursts support the hypothesis that high-level chirps evoke a broader spread 
of synchronous neural firing along the cochlear partition than high-level low frequency (2 kHz) 
tonebursts.  On average, the NDF bandwidths for chirps at 90 dB pSPL were 1.5 times broader and 
peaked nearly 2 mm closer to the base of the cochlea than those for 2 kHz tonebursts at 90 dB pSPL (Fig. 
8, left panel).  The NDF bandwidth comparison across stimulus type for the moderate level of 60 dB 
pSPL (Fig. 8, right panel) suggests that moderate-level 2 kHz tonebursts evoke a larger spread of 
synchronous neural firing than moderate-level chirps.  However, as displayed in the bottom right panel of 
Figure 7, NDF bandwidth for 2 kHz tonebursts at 60 dB pSPL was highly variable.  The NDF peak 
location for 2 kHz tonebursts at 60 dB pSPL was also considerably more variable than for chirps at 60 dB 
pSPL, but the mean data suggest that the distribution of neural firing evoked by moderate-level chirps 
peaks significantly closer to the base than for moderate-level low frequency tonebursts.   
Experiment 2: NDF Comparisons across Groups 
 The negligible differences between high-level NDFs for the normal-hearing and gentamicin-
exposed groups (Fig. 10, bottom left panel) support the hypothesis that gentamicin-induced OHC 
pathology does not significantly alter the spread of neural firing evoked with high-level stimuli.  The 
secondary observation that gentamicin-induced OHC pathology did significantly alter the peak location of 
NDFs constructed with chirps at a moderate level (i.e., 60 dB pSPL; Fig. 10, bottom right panel) is 
consistent with previous research (e.g., Dallos and Harris, 1978; Ruggero and Rich,1991; Fridberger et 
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al., 2002) suggesting OHCs act primarily to enhance basilar membrane displacement for low to moderate-
level inputs. 
Despite receiving the same 200 µg dose of gentamicin, the peak location of post-gentamicin 
NDFs for chirps at 60 dB pSPL (Fig. 10, bottom right panel) varied by as much as 2 mm.  This 
observation suggests inter-animal differences in gentamicin susceptibility that are consistent with the 
results of Wanamaker et al. (1998) indicating differing amounts of hair cell damage in gerbils receiving 
equivalent transtympanic doses of gentamicin.  The significant negative correlation (r = -0.74; p = 0.003) 
between the shift in peak location for moderate-level NDFs and chirp CAP threshold shift (Fig. 11) 
suggests that chirp CAP threshold shifts may provide an estimate of gentamicin-induced shifts in neural 
firing evoked with moderate-level stimuli. 
Unmasked CAP Amplitudes 
The chirp CAP waveforms displayed in Figure 5 and in Appendix C were considerably larger in 
amplitude and had narrower N1 morphology than 2 kHz toneburst CAPs.  These observations suggest that 
chirps generate synchronous neural firing across a larger number of auditory neurons than 2 kHz 
tonebursts.  Figure 5 also illustrates that, on average, chirps at 90 dB pSPL yield smaller CAP amplitudes 
than chirps at 60 dB pSPL.  This finding may be related to the fact that the chirp used in this study was 
constructed with near-threshold CAP latency data and its instantaneous frequency was not adjusted to 
account for differences in the traveling wave velocity across different signal levels (Fobel and Dau, 
2004).  Dau et al. (2000) also held the instantaneous frequency of their chirp stimulus constant across 
level and observed a similar roll-off in wave-V amplitude of ABRs evoked with high-level chirps. 
The across-animal coefficients of variation (CV) of the unmasked CAP amplitude were smaller 
for chirps (0.24 for 90 dB pSPL, 0.16 for 60 dB pSPL) than for 2 kHz tonebursts (0.32 for 90 dB pSPL, 
0.24 for 60 dB pSPL) suggesting that chirp CAP amplitude is more stable across animals for a given 
stimulus level than 2 kHz toneburst CAP amplitude.  The mean within-animal CV of unmasked CAP 
amplitude was larger for chirps at 90 dB pSPL (0.11) than for 2 kHz tonebursts at 90 dB pSPL (0.06) 
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suggesting that high-level chirp CAP amplitude is slightly less stable over a recording session in one 
animal than high-level toneburst CAP amplitude.  The opposite was observed for the CV of the unmasked 
CAP amplitude for the two stimuli at 60 dB pSPL (chirps = 0.04; 2 kHz tonebursts = 0.08) suggesting that 
chirp CAP amplitude at that level is more stable during one recording session than 2 kHz toneburst CAP 
amplitude. 
CAP Latency Shifts 
As mentioned above in the Results section, N1 latency data were not analyzed in depth for this 
study but are shown in Appendix D.  Figure D.1 displays the data for the four stimulus conditions of 
Experiment 1 and Figure D.2 shows the data for the two stimulus conditions of Experiment 2.  Both 
figures plot the shifts in N1 peak latency (masked-unmasked latency) as a function high-pass noise cutoff 
frequency.  The horizontal line at zero represents the baseline peak latency for unmasked CAPs.  The 
latency shift functions are generally consistent with the theory suggested by Teas et al. (1962) and the 
data from others (e.g. Elberling, 1974, Don et al., 1979, Evans and Elberling, 1982) that the location of 
synchronous neural firing for moderate and high-level stimuli is “pushed” toward the apex proportional to 
the high-pass cutoff frequency of masking noise.  The trends in latency shift resemble the inverse of the 
patterns observed for N1 amplitude growth.  The latency functions for the gentamicin-exposed group in 
Experiment 2 (Fig. D.2) show smaller shifts in latency and more variability when compared to the trends 
of the chirp CAP latency functions of the normal-hearing group. 
Chirp Stimulus 
As mentioned above, the instantaneous frequency, and therefore the duration, of the chirp 
stimulus used in this study was held constant for both stimulus levels (i.e., 60 and 90 dB pSPL).  In 
addition to being smaller in amplitude than chirp CAPs at 60 dB pSPL, chirp CAPs at 90 dB pSPL (e.g. 
Fig. 3, left panel; Fig. C.1) also had broader N1 morphology than responses at 60 dB pSPL (Fig. 5, top 
right panel; Fig. C.2).  Generating level-specific chirps may further optimize neural synchrony and 
increase amplitudes of high-level chirp CAPs. 
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Considering the entire span of the mean high-level NDF for chirps (Fig. 8, right panel), the chirp 
stimulus was effective in triggering neural firing across 8.5 mm (3 to 11.5 mm from the apex) of the 
cochlear partition.  However, the apparent lack of apical neural firing before the 3 mm location suggests 
that dropping the low-frequency edge of the chirp spectrum from 1 kHz to 250 or 500 Hz and/or 
increasing the spectral magnitude of the low frequency energy of the chirp may further extend neural 
firing towards the apex.  Extending the high-frequency edge of the chirp spectrum past 60 kHz and adding 
2-3 masker cutoff frequencies above 45 kHz may also improve identification of the saturation point of N1 
amplitude growth functions for high-level chirps (e.g. Fig. 6, top left panel). 
High-Pass Noise Masking Paradigm 
Similar to the high-pass noise masking paradigms used in previous studies (e.g., Teas et al., 1962; 
Shore and Nuttall, 1985; see Literature Review in Appendix A), the masking paradigm in this study led to 
decreases in N1 amplitude and increases in N1 latency with decreases in the high-pass noise cutoff 
frequency (e.g. Fig. 3, right panel).  However, the masking paradigms of previous studies have generally 
included 6-8 high-pass cutoff frequencies representing octave intervals (e.g. Teas et al., 1962; Don et al., 
2005) with one exception: the study in guinea pig by Shore and Nuttall (1985) used 18 cutoff frequencies 
representing 1/3 octave increments between 0.4 and 20 kHz.  The masking paradigm of the current study 
included 25 cutoff frequencies representing 0.25 mm increments along the first 3 mm of the basal turn 
and 0.5 mm increments for the middle through apical regions of the gerbil cochlea (3-11 mm) to provide 
distance-based amplitude growth functions with relatively high resolution.  The technique of deriving 
neural density functions from cumulative amplitude (sigmoid) functions describing the N1 amplitude 
growth data is novel.  Previous studies have primarily focused on calculating derived band waveforms to 
infer regional cochlear contributions to the CAP as well as predicting behavioral hearing thresholds (see 
Literature Review in Appendix A). 
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Sigmoid Model Performance 
The mean (R
2
) values for the CAF fits of both experiments suggest that the four-parameter 
sigmoid function accounts for a large majority of the variance in the N1 amplitude data for all stimulus 
conditions.  For Experiment 1 (Fig. 6), the sigmoid function achieved the best fit for the amplitude data 
for chirps at 60 dB pSPL with a mean R
2 
of 0.99 (range = 0.985-0.998).  The lowest mean R
2
 of 0.92 
(range = 0.796-0.976) was observed for the fits of the amplitude data for chirps at 90 dB pSPL.  The 
lower values and larger range for the R
2
 values for the fits of the data for chirps at 90 dB pSPL is not 
unexpected given the lack of a definite point of saturation for the majority of the amplitude growth 
functions.  Accordingly, the parameter a, which scales the inflection point of N1 amplitude growth, had to 
be manually constrained for 7 of the 9 fits of the amplitude data for chirps at 90 dB pSPL.  Without 
manual constraints, the parameter a was not significant and the fitted function tended towards exponential 
growth.  For each of the other three stimulus conditions, the parameter a only had to be manually 
constrained for 1 of the 9 fits.  The parameter b, that governs the rate of growth of the CAF, also required 
manual constraints to be retained as a significant parameter and/or to preserve constant variance in 3 of 
the 9 fits of the data for chirps at 90 dB pSPL and 1 of the 9 fits of the data for 2 kHz tonebursts at 60 dB 
pSPL.  For Experiment 2 (Fig. 10, top panels), the R
2
 values for the post-gentamicin CAFs for chirps at 
90 dB pSPL ranged from 0.89 to 0.97.  Similar to the CAF fits of the normal data for chirps at 90 dB 
pSPL, the sigmoid parameter a had to be manually constrained for the majority of animals (9 out of 10) to 
achieve significance for all parameters.  The R
2 
values for the post-gentamicin CAFs for chirps at 60 dB 
pSPL ranged from 0.92 to 0.98 and no manual constraints of the sigmoid parameters were necessary.  
Objectivity in choosing manual constraints was maintained by focusing on the goal of maximizing the R
2
 
value while retaining significance for all four parameters.   
Alternative Method of Analysis 
Taking the analytical derivative of the four-parameter sigmoid function (Eq. 2) used to fit the N1 
amplitude growth data dictates NDFs with one peak and a smooth distribution (Fig. 8 and Fig. 10).  
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However, the subtle fluctuations in the normalized N1 amplitude data may provide valuable information 
for differential diagnosis.  An alternative analysis method that would preserve the “fine-structure” of 
neural firing involves bypassing the sigmoid fits and plotting the numerical derivative of the normalized 
N1 amplitude data (e.g., Fig. E.1, Appendix E).  Comparing the numerical NDFs (Fig. E.1) to the 
corresponding analytical NDFs (Fig. 8 and Fig. 10, bottom panels) reveals that the NDFs for high-level 
chirps differ considerably between the two approaches.  For example, the mean analytical NDF for chirps 
at 90 dB pSPL in Experiment 1 (Fig. 8, left panel) suggests that neural firing density accumulates 
gradually beginning at approximately 3 mm from the apex whereas the mean numerical NDF for the same 
data captures a bump in neural firing density between 1 and 4 mm from the apex.  The most prominent 
peak of the three-peaked numerical NDF for chirps at 90 dB pSPL occurs at approximately 10 mm from 
the apex suggesting that peak firing density is nearly 2 mm closer to the base than suggested by the 
analytical NDF (8.22 mm from apex).  Constructing NDFs in this manner also avoids the dilemma of 
choosing manual constraints for sigmoid fits of quasi-sigmoid data (e.g., amplitude functions for chirps at 
90 dB pSPL). 
Future Directions 
Building on the outcomes of this study, the next experiment will be launched to determine if 
high-level neural density functions are correlated with the distribution of surviving auditory neurons in 
animals with partial lesions of the auditory nerve.  If CAP-derived NDFs can reliably predict the extent 
and location of neural pathology, a similar masking paradigm could then be implemented in 
electrocochleography recording protocols for human patients.  Automation of the masker presentations 
and corresponding CAP recordings would allow extra time for repeat sweeps through the entire masking 
protocol.  Automation would also aid in quickly constructing NDFs for chirps across a range of signal 
levels (e.g., near threshold to high levels) in normal and impaired ears.  Additional examinations of the 
data collected for this study to assess the fine-structure of individual numerical NDFs, to plot derived-
band waveforms, and to analyze masked latency shifts may also provide valuable information. 
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CONCLUSIONS 
1. Chirp stimuli evoke large CAPs with clear morphology and minimal signal averaging making them 
advantageous for use in clinical situations where test time may be limited. 
2. High-level chirps trigger a broader spread of synchronous neural firing along the cochlear partition 
than high-level low frequency (2 kHz) tonebursts indicating that chirps are superior stimuli for 
mapping auditory nerve density across the majority of the cochlea with a high-pass masking 
paradigm. 
3. Gentamicin-induced OHC pathology does not significantly alter the distribution of neural firing 
evoked by high-level chirps pointing to their utility in providing reliable maps of auditory nerve 
density in impaired ears. 
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Introduction 
 The development of diagnostic techniques to map auditory nerve survival may improve 
techniques for treating sensorineural hearing loss with hearing aids and cochlear implants and guide 
future implementation of regenerative therapies.  This literature review focuses first on research related to 
the time course of auditory nerve degeneration secondary to organ of Corti damage and aging, and the 
capability of current clinic tools to diagnose auditory nerve degeneration.  The focus will then shift to a 
review of several studies that have investigated the use of novel stimuli and masking paradigms to 
improve the performance of AEP measures for differential diagnosis of sensorineural hearing loss.  
Lastly, a summary is given of studies that have used gentamicin to induce OHC pathology in animal 
models and others that have investigated the effect of OHC pathology on CM and high-level CAP 
recordings. 
Auditory Nerve Degeneration 
Several studies of human temporal bones from elderly donors in the late 1800s and early 1900s 
(reviewed by Bredberg, 1968) found auditory nerve degeneration at the level of the osseous spiral lamina 
and the spiral ganglion cells (SGCs) to be the most common anatomical defect in the basal region of the 
cochlea.  In these and later studies, concomitant atrophy of the organ of Corti was not always observed 
with auditory nerve degeneration (Bredberg, 1968; Spoendlin, 1975, 1984).  When atrophy of the organ 
of Corti was observed, nerve degeneration was usually present but the extent of degeneration did not 
always correlate with the extent of loss of hair cells and supporting cells (Bredberg, 1968).  Spoendlin 
(1975) observed that loss of IHCs and disruption of the blood supply to the cochleae of guinea pig and cat 
induced substantial retrograde degeneration in afferent auditory neurons.  He also observed in other 
cochleae that OHC loss alone or supporting cell damage alone did not lead to significant nerve 
degeneration.  Nerve degeneration without IHC loss was uncommon, but such observations suggested 
direct damage to dendrites of Type I afferents and/or other demyelinating conditions. 
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Spoendlin (1984) described two general categories of neural degeneration following axonal 
lesions; wallerian degeneration and secondary retrograde degeneration.  Wallerian degeneration refers to 
atrophy of the axonal region that is separated from the neuronal cell body by a lesion.  Secondary 
retrograde degeneration involves degeneration of the portion of the neuron containing the cell body.  For 
type I afferent neurons that predominantly supply the IHCs of the cochlea, wallerian degeneration would 
refer to degeneration that begins at a dendritic lesion and progresses toward the synaptic connection with 
an IHC.  Secondary retrograde degeneration of afferent auditory neurons progresses centrally from the 
axonal lesion toward the cell body in the spiral ganglion, eventually affecting the entire length of the 
neuron.  Spoendlin (1984) states that wallerian degeneration has been observed to occur within hours in 
motor neurons while secondary retrograde degeneration in afferent neurons normally progresses over 
months and years. 
Spoendlin’s (1975) review of the data from guinea pig suggested that the process of retrograde 
degeneration in the auditory nerve following acoustic, mechanical, or ototoxic lesions to the cochlea 
begins with swelling of the peripheral dendrites and eventual rupture of the axonal membranes.  
Retrograde degeneration then progresses within days through the osseous spiral lamina to the level of the 
spiral ganglion.  Subsequent degeneration and disappearance of SGCs occurs after several weeks with 
approximately 10% of SGCs surviving five months following cochlear lesions in guinea pig.  Even one 
year post-lesion, 5-10% of the SGCs still appeared to be healthy.  Other data cited by Spoendlin (1975) 
from congenitally deaf white cats suggested that 5-10% of SGCs remain viable over an eight year period.  
Significant numbers of surviving auditory neurons have also been observed in human temporal bones 
from donors with genetic conditions affecting the development and morphology of the organ of Corti 
(Spoendlin, 1975).  In contrast, animal experiments involving disruption of the blood supply to the 
cochlea, found complete loss of viable auditory neurons (Spoendlin, 1975). 
Other studies of human temporal bones aimed to find a relationship between the donors’ 
audiometric records and the histological status of cochlear structures and auditory neurons.  The early 
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work of Guild et al. (1931) documented atrophy of the organ of Corti and/or decreased innervation 
density in the basal region of the majority of cochleae from 15 patients with pre-mortem audiometric 
records showing elevated high frequency hearing thresholds.  Crowe et al. (1934) also analyzed the 
temporal bones of 79 donors with moderate to severe high frequency hearing loss and found 75% of the 
cochleae to have basal atrophy of the organ of Corti and partial degeneration of the auditory nerve.  The 
extent of nerve degeneration was observed to be greater in those ears with thresholds in the severe hearing 
loss range.  These studies were followed by the extensive work of Schuknecht and colleagues 
(Schuknecht, 1955; Schuknecht, 1964; Otte et al., 1978; Suzuka and Schuknecht, 1988; Schuknecht and 
Gacek, 1993; Schuknecht, 1994) who suggested that the pathology contributing to presbycusis could be 
differentiated by audiometric shape.  For example, Schuknecht and Gacek (1993) looked at serial sections 
of human temporal bones from 21 donors with audiometric records showing symmetric bilateral 
sensorineural hearing loss without any history of ear disorders or other risk factors for hearing loss.  Their 
results suggested that a sharp drop in high frequency hearing thresholds resulted from atrophy of the 
organ of Corti and loss of hair cells and that unexpectedly poor word recognition ability was associated 
with degeneration and/or loss of auditory neurons.  A uniform decline in hearing thresholds across 
frequency (i.e., flat audiometric pattern) was attributed to atrophy of the stria vascularis.  Other patterns of 
presbycusis were thought to suggest a combination of several different cochlear and/or neural pathologies. 
In contrast, findings of other temporal bone studies (e.g., Suga and Lindsay, 1976; Felder and 
Schrott-Fischer, 1995; Bhatt et al., 2001; Nelson and Hinojosa, 2003; Ohlemiller, 2004) have suggested 
that audiometric patterns of hearing loss could not consistently identify the location nor the extent of 
cochlear and neural pathology.  For example, Nelson and Hinojosa (2003) analyzed the histological status 
of cochlear structures and auditory neurons of six patients with flat audiometric patterns of sensorineural 
hearing loss to test the idea that strial atrophy was responsible for this pattern.  Their results indicated that 
only one of the six temporal bones examined had significant strial atrophy.  Instead, all six cochleae had a 
statistically significant reduction in OHCs.  Three of the six cochleae also showed a statistically 
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significant reduction in IHCs.  Recent reviews by Mills (2006) and Nelson and Hinojosa (2006) also 
highlight data suggesting the limitations of behavioral audiometric tests for differential diagnosis of the 
underlying pathophysiology leading to sensorineural hearing loss and urge a test battery approach 
involving OAEs and AEPs. 
In their 1953 study, Schuknecht and Woellner assessed both behavioral hearing thresholds and 
cortically evoked auditory potentials in six cats with partial lesions of the auditory nerve.  Their results 
indicated that behavioral and electrophysiologic thresholds remained within the normal range with as 
much as an 80% loss of SGCs.  However, when Schuknecht and Woellner (1953) measured the N1 
portion of the cortical response they observed that the maximum amplitude of N1 decreased with 
increasing amounts of SGC degeneration.  Hall (1990) induced varying degrees of spiral ganglion 
degeneration with neomycin in 16 rats and found strong positive correlations between the maximum 
amplitude of the first positive peak of electrically evoked ABR responses and the number of surviving 
ganglion cells.  In a mouse model of noise exposure, Kujawa and Liberman (2008) also found that ABR 
amplitudes at high stimulus levels were better than thresholds in predicting auditory neuron degeneration.  
The strong positive correlations between maximum CAP amplitude and auditory nerve survival described 
by Earl and Chertoff (2010) are consistent with the findings of these previous studies and suggest that 
CAP amplitude may be a valuable diagnostic measure for predicting auditory nerve survival. 
Influence of Stimulus Characteristics on AEPs 
 The acoustically-evoked CAP represents the synchronous firing of multiple auditory neurons 
(Goldstein and Kiang, 1958).  The click-evoked CAP has also been called the whole nerve action 
potential (e.g. Teas et al., 1962; Dolan et al., 1983) because clicks, which have broadband acoustic 
spectra, theoretically trigger firing in the majority of auditory nerve fibers along the cochlear partition 
(assuming that the frequency response of the transducer does not truncate the bandwidth of the stimulus).  
However, recordings in cat (Dolan et al., 1983) and in guinea pig (Eggermont, 1976) suggested that round 
window CAP recordings are dominated by the summed response of basal nerve fibers even when 
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broadband acoustic stimuli are used since the discharge latencies of high frequency fibers are similar.  
Nerve fibers innervating the middle to apical regions of the cochlea may also respond to broadband 
stimuli; however, their discharge latencies are delayed proportionally by the traveling wave delay leading 
to temporal smearing and limited contributions to the CAP (Dolan, 1983). 
Chirp stimuli (i.e., rising frequency tonebursts) theoretically compensate for the cochlear 
traveling wave delay and evoke synchronous neural firing across a large portion of the basilar membrane.  
The instantaneous frequency of chirp stimuli is swept from low to high frequencies according to a time 
constant that allows individual frequency components to arrive simultaneously at their characteristic 
place, leading to synchronous displacement along the basilar membrane (Shore and Nuttall, 1985).  The 
findings of several studies (e.g. Shore and Nuttall, 1985; Fobel and Dau, 2004; Elberling et al., 2007; 
Elberling and Don, 2008; Don et al., 2009) and recordings in our lab (Fig. 5) indicate that chirp stimuli 
consistently yield larger response amplitudes than clicks and traditional toneburst stimuli. 
Shore and Nuttall (1985) used a guinea pig model to compare CAPs evoked with standard chirps 
with rising frequency to CAPs evoked with reverse chirps with falling frequency.  The frequency 
bandwidth and magnitude of both stimuli were equated but the frequency of the rising chirp was swept 
from 0.3 to 6 kHz while the frequency of the falling chirp was swept from 6 to 0.3 kHz.  The time 
constant dictating the instantaneous frequency was determined with the frequency-place map data for 
guinea pig from Greenwood (1961).  The falling frequency chirps were expected to induce neural firing 
that was more temporally disperse than for rising frequency chirps since the falling chirps began with 
high frequency energy that would trigger firing in the base before the low frequency energy reached the 
apex.  Shore and Nuttall’s (1985) results showed that the N1 component of CAPs evoked at low stimulus 
levels (15 dB above CAP threshold) with rising frequency chirps was significantly more narrow and 
larger in amplitude than N1 of CAPs evoked with falling frequency chirps at low levels suggesting that 
the rising chirps triggered more synchronous firing than falling frequency chirps.  In a study in human 
participants with a similar experimental design, Chertoff et al. (2010) also found that rising frequency 
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chirps evoked larger CAPs than both falling frequency (i.e., reverse) chirps and traditional click stimuli of 
equivalent magnitude and spectral bandwidth. 
Other researchers (e.g. Dau et al., 2000; Wegner and Dau, 2002; Fobel and Dau, 2004; Elberling 
et al., 2007; Elberling and Don, 2008) have tested the utility of chirp stimuli for improving the signal to 
noise ratio of ABR recordings.  For example, Dau et al. (2000) recorded ABRs in 10 human participants 
with normal hearing with a chirp stimulus that was designed based on the cochlear model of De Boer 
(1980) and the frequency-place map data of Greenwood (1990).  De Boer’s (1980) model provided an 
equation for instantaneous phase based on the velocity of the traveling wave in the fluid-filled cochlea.  
Greenwood’s (1990) data allowed place along the basilar membrane to be matched to its characteristic 
frequency.  The results of Dau et al. (2000) indicated that wave V amplitude of ABRs evoked with chirps 
was significantly larger than the wave V amplitude of ABRs evoked with clicks when the sensation level 
of both stimuli were equated by the participants.  The enhanced wave V amplitude for chirp-evoked 
ABRs was more pronounced at relatively low levels (e.g. 10-40 dB SL re: ABR threshold).  This 
observation both suggests that chirp stimuli could improve threshold detection and that the time constant 
governing the instantaneous phase of chirps may need to be adjusted according to stimulus level.  Don et 
al. (2009) also suggested that the ideal chirp design would account for individual variations in cochlear 
anatomy. 
Fobel and Dau (2004) also measured chirp-evoked ABRs and confirmed that chirp stimuli 
yielded larger wave V amplitudes than click stimuli.  In addition to using the chirp stimulus with the 
design described by Dau et al. (2000), Fobel and Dau (2004) compared the ABRs evoked with two other 
chirp stimuli; one derived from basilar membrane delay data based on stimulus frequency OAE measures 
from Shera and Guinan (2000), and another chirp with its instantaneous frequency derived from wave V 
latencies from toneburst ABR data from Neely et al. (1988).  Fobel and Dau (2004) found that the most 
effective chirp stimulus (i.e., chirp that produced largest wave V amplitude) was the chirp designed with 
the toneburst ABR latency data.  At low stimulus levels, the wave V amplitude of ABRs evoked with this 
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chirp design was triple the size of those evoked with click stimuli.  Fobel and Dau (2004) interpreted this 
finding to suggest that chirps designed with electrophysiological measures may be superior to those 
designed with OAE data since electrophysiological data essentially involve both the mechanical and 
neural-related delays of the cochlea. 
Elberling et al. (2007) have also found chirp stimuli to be effective in increasing the signal to 
noise ratio and reducing response detection times for recordings of the auditory steady-state response 
(ASSR) at low and moderate stimulus levels (30 and 50 dB nHL, respectively).  Elberling and Don (2008) 
and Don et al. (2009) compared amplitudes of ABRs obtained with various chirp stimuli to ABR 
amplitudes derived with the stacked-ABR technique (Don et al., 2005) that involves click stimuli and 
high-pass masking noise.  Using a stimulus level of 50 dB nHL, Elberling and Don (2008) found that the 
amplitude of chirp-evoked ABRs was nearly equivalent to the amplitude of stacked ABRs.  Don et al. 
(2009) indicated that an ABR recording protocol using chirp stimuli could detect small acoustic tumors 
with a specificity of 85% with sensitivity set at 95% and required approximately 1/6 the testing time 
needed for a stacked-ABR protocol. 
Masked AEPs 
The use of chirp stimuli to evoke AEPs has been described as a form of “input compensation” for 
the cochlear traveling wave delay while the use of masking to isolate particular regions of neural activity 
has been called “output compensation” (Don et al., 2009).  The stacked-ABR technique is a well known 
example of using masking noise to compensate for the temporally disperse neural output triggered by 
click stimuli.  The stacked-ABR described by Don et al. (2005) represents the sum of five derived-band 
ABR waveforms that have been temporally aligned according to the latency of wave V.  The responses 
are called derived-band ABRs because they represent the difference waveform resulting from subtracting 
a masked ABR from an unmasked click-evoked ABR.  The masked ABRs are recorded during 
simultaneous masking with broadband noise that is high-pass filtered with five different cutoff 
frequencies representing octave intervals between 0.5 and 8 kHz.  Don et al. (2005) tested the stacked-
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ABR protocol in a group of 54 patients that either had an acoustic tumor less than one centimeter in size 
or had a tumor that was not detected by a standard ABR protocol involving wave V latency comparisons.  
Relative to MRI detection of the tumor, the stacked-ABR technique identified 100% of the tumors with a 
specificity of 50%.  With a slightly lower sensitivity of 95%, the technique reached a specificity of 88%. 
An earlier study by Teas et al. (1962) described the use of band-pass masking noise to derive 
narrow-band CAPs in guinea pig.  Teas and colleagues used intracochlear electrodes to record CAPs to 
click stimuli during simultaneous masking with narrow bands of white noise with six different center 
frequencies.  Their results indicated that narrow-band CAPs varied in peak amplitude and latency but 
summed to equal the unmasked CAP response.  In two similar studies, Bone et al. (1972) and Prijs and 
Eggermont, (1981) used high-pass noise to derive narrow-band CAPs to clicks recorded from the round 
window in rat and guinea pig.  Similar to the findings of Teas et al. (1962), they found that N1 amplitude 
and N1 latency varied proportionally with the high-pass cutoff frequency.  The results of Bone et al. 
(1972) made them optimistic that the high-pass masking technique could be incorporated with 
electrocochleography protocols to obtain a location-specific diagnosis of cochlear pathology in human 
patients. 
The utility of a high-pass masking paradigm in CAP and ABR recordings in animal and human 
participants has been examined in many studies (e.g., Crowley et al., 1972; Elberling, 1974; Eggermont, 
1976; Spoor et al., 1976; Zerlin and Naunton, 1976; Don and Eggermont, 1978; Don et al., 1979; Shore 
and Nuttall, 1985; Wegner & Dau, 2002).  The study of Elberling (1974) provided an estimate of the 
traveling wave velocity in humans based on the latencies of CAPs evoked with high-level clicks (95 dB 
peak equivalent SPL) during simultaneous masking with broadband noise high-passed at octave intervals 
between 0.5 and 8 kHz.  Eggermont’s (1976) work included transtympanic CAP recordings in human 
participants and round window CAP recordings in guinea pig.  Similarities between the response areas 
constructed with derived-band amplitudes for humans and those constructed for guinea pigs were 
interpreted by Eggermont (1976) to suggest that the results of animal experiments involving round-
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window CAP recordings may generalize to human patients.  Don et al. (1979) applied the high-pass 
masking technique to click-evoked ABR recording protocols with the goal of obtaining an estimate of the 
behavioral audiogram in humans.  Their results from three patients with different audiometric 
configurations (e.g., 4 kHz notch, rising low frequency, and flat) suggested that narrow-band ABR 
thresholds matched behavioral thresholds reasonably well (e.g., within 5-15 dB).  Don et al. (1979) also 
detailed several potential drawbacks and limitations of clinical application of the technique including long 
test-time and the likely mismatch between electrophysiologic thresholds and audiometric thresholds in 
patients with retrocochlear tumors and severe low frequency hearing loss. 
Parker and Thornton (1978 a, b, c) expressed concern as to the validity of inferring regional 
cochlear activity from derived-band ABRs recorded from the scalp.  However, after comparing derived-
band latencies from ABRs recorded in normal hearing human participants to published estimates of the 
traveling wave velocity, the authors concluded that the derived band technique seemed to be valid (Parker 
and Thornton, 1978 c).  Evans and Elberling (1982) also designed an experiment to validate the use of the 
high-pass masking technique for deriving narrow-band CAP responses.  In cat, they recorded click-
evoked single-fiber activity and round window CAPs simultaneously during high-pass noise masking at 
various cutoff frequencies.  Decreases in single-fiber activity, quantified with post-stimulus time 
histograms, coincided directly with decreases in CAP amplitude suggesting that a high-pass masking 
paradigm could provide an accurate survey of regional neural firing along the basilar membrane. 
The use of notched-noise in combination with toneburst stimuli has also been investigated by 
several researchers (e.g., Picton et al., 1979; Stapells and Picton, 1981; Stapells et al., 1990; Stapells et 
al., 1995).  The primary goal of these investigations was to determine if notched noise could reduce the 
frequency spread of brief tonebursts and allow accurate estimates of frequency-specific hearing 
thresholds.  The data of Picton et al. (1979) suggested that the notched-noise protocol yielded toneburst 
ABR thresholds that were within 20 dB of behavioral pure-tone thresholds.  A similar study by Stapells et 
al. (1995) of 34 children with normal hearing and 54 children with sensorineural hearing loss indicated 
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that the large majority of ABR thresholds estimated with tonebursts centered in notched-noise were 
within 15-30 dB of behavioral thresholds.  Picton et al. (1979) also acknowledged concern regarding the 
possible upward spread of masking from the acoustic energy from the low frequency side of the notched 
noise.  The upward spread is likely most pronounced when using high-level toneburst stimuli that require 
higher noise levels to provide sufficient masking of the toneburst side lobes.  This very concern lead to an 
early change in the experimental design of this study from using high-level tonebursts embedded in 
notched noise to high-level chirps with a high-pass masking paradigm. 
Gentamicin-Induced Impairment of OHCs 
The effects of gentamicin on cochlear hair cells has been studied in chicks (Husmann et al., 
1998), pigeons (Müller and Smolders, 1998), mice (Heydt et al., 2004), and gerbils (Wanamaker et al., 
1998; Sheppard et al., 2004; Suryadevara et al., 2009) by applying gentamicin directly to the round 
window.  The use of a drug delivery vehicle (e.g. Gelfoam®) has also been shown to produce hair cell 
damage more reliably and more extensively than directly dripping gentamicin into the round window 
niche in chicks (Hussman et al., 1998) and gerbils (Sheppard et al., 2004).  Other studies (e.g., Ylikoski, 
1974; Ylikoski et al., 1974; Szymanski et al., 1994) have used systemic injections of gentamicin or other 
aminoglycoside antibiotics to induce hair cell pathology in animal subjects.  However, the systemic 
dosages required to induce substantial hair cell pathology were frequently toxic and/or lethal to the 
animals.  Round window application of gentamicin prevents systemic toxicity and also allows the 
opposite ear to serve as a control for anatomical comparisons (e.g., Husmann et al., 1998). 
Husmann et al. (1998) used 11-day old chicks in their experiment and found that directly dripping 
gentamicin into the round window niche resulted in either minimal damage to the cochlea (~5-10% of 
length of cochlea) or no visible damage at all.  In contrast, when the same amount of gentamicin was 
infused into a Gelfoam ® pledget and placed on the round window, hair cell damage was observed along 
50-100% of the length of the chick cochleae.  Husmann et al. (1998) also observed that a gentamicin dose 
of 0.5 mg (500 µg) and an exposure time of only 30 minutes resulted in damage across 50% of the length 
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of the cochlea.  Higher doses (e.g., 1.0 mg) and exposure times as long as 5 days resulted in 80-90% of 
the length of the cochlea being damaged.  Sheppard et al. (2004) compared Gelfoam-based delivery 
vehicles to other vehicles (i.e., hyaluronic acid and fibrin) in gerbils and found that the Gelfoam-based 
vehicle produced the most homogenous damage across animals.  Specifically, gerbils that received two 
weeks of gentamicin exposure via Gelfoam® delivery vehicles, sustained hair cell damage throughout 90-
100% of the cochlea while other vehicles resulted in less complete and more variable damage. 
Müller and Smolders (1998) analyzed ABR thresholds and hair cell anatomy in pigeons following 
gentamicin administration to the round window via Gelfoam ®.  Data from 21 ears that received a 0.5 mg 
dose of gentamicin suggested that ABR threshold shifts and hair cell morphology changes occurred 
within five days post-exposure.  ABR thresholds for middle and high frequency stimuli shifted 40-70 dB 
while the thresholds for low frequency stimuli shifted by only 10-20 dB.  Scanning electron microscope 
images of the hair cell anatomy showed nearly complete destruction of hair cells across the entire length 
of the cochlea (i.e., basilar papilla) by seven days after gentamicin exposure. 
Heydt et al. (2004) used mice (n = 82) to determine the effect of round-window application of 
gentamicin (delivered via Gelfoam®) on OHCs and IHCs.  Their data indicated that a 25 µg dose of 
gentamicin resulted in OHC damage throughout the basal and middle cochlear turns but minimal IHC 
damage after 24 hours.  Sheppard et al. (2004) used a much higher gentamicin dose of 445 µg in gerbil 
with a two-week survival period and observed nearly equal damage to OHCs and IHCs.  The study of 
Suryadevara et al. (2009) included a group of two gerbils that were exposed to gentamicin-soaked fibrin 
clots on the round window.  Fibrin is described as gel-like material that is made by combining bovine-
derived fibrinogen and thrombin.  Two weeks post-application of the gentamicin, histologic observations 
indicated that 65% of OHCs and 49% of IHCs remained intact. 
Although the data of Sheppard et al. (2004) and Suryadevara et al. (2009) indicate that long-term 
(e.g., 2 weeks) exposure to gentamicin results in damage to the OHCs and IHCs in gerbil, observations 
over shorter time increments (e.g., hours to days) in gerbil (Wanamaker et al., 1998), guinea pig (Ylikoski 
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et al., 1974), and mouse (Heydt et al., 2004) have indicated that gentamicin exposure damages OHCs 
before IHCs.  Ylikoski et al. (1974) used light microscopy to sequentially observe the effect of gentamicin 
and kanamycin on the inner ear structures of guinea pig.  In the majority of 42 ears, Ylikoski et al. (1974) 
noted that SGCs and IHCs remained normal in appearance when OHC damage was widespread. 
Wanamaker et al. (1998) summarized the findings of several animal studies that have investigated 
the time-course of the ototoxic effects of gentamicin and other aminoglycosides.  The time-course of 
aminoglycoside effects has largely been determined by studies using systemic injections of 
aminoglycosides followed by blood and perilymph samples. Within 3-5 hours post-injection, peak levels 
of aminoglycosides are detected in the perilymph of the cochlea.  The drug is also detectable in the 
endolymph but at lower levels and after more time post-injection.  The half-life of aminoglycosides, or 
the rate at which they are eliminated, ranges from 3 to 15 hours post-injection. 
The mechanisms behind the ototoxic effects of aminoglycosides have been investigated at the 
molecular level by several investigators.  Williams et al. (1987) and Blanchet et al. (2000) isolated OHCs 
from guinea pig and studied the effects of gentamicin in vitro.  The key finding of both studies was that 
gentamicin displaced calcium cations from OHCs suggesting a direct influence of aminoglycosides on 
three OHC properties controlled by calcium; membrane stability, excitability, and slow motility.  
Williams et al. (1987) found that once gentamicin crossed the OHC membrane, it proceeded to bind with 
phospholipid elements that maintain the integrity of the cell membrane.  This interference would then 
likely disrupt hydrolysis processes that are necessary for cell survival.  Li and Steyger (2009) reviewed 
several other studies that identify non-selective cation channels and stereocilia tip channels as likely OHC 
entry points for gentamicin.  Other possible entry points into the cochlea include marginal cells of the 
stria vascularis, endothelial cells of the lateral wall, and the tight-junction cells of Reissner’s membrane 
and the basilar membrane (Li and Steyger, 2009). 
Li and Steyger (2009) also described a synergistic effect of exposure to aminoglycosides and 
noise exposure.  Brown et al. (1978) investigated the effect with a 7-day experiment in guinea pig that 
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involved daily subcutaneous injections of neomycin (200 mg/kg) and a daily 10-hour exposure to high-
level (115 dB SPL) white noise (bandwidth = 0.5-10 kHz).  Compared to a neomycin-only control group 
that experienced a 17 dB shift in CM thresholds and a noise-only group that experienced a 16 dB shift in 
CM thresholds, a mean shift of 62 dB was observed for the neomycin plus noise group.  Histological 
comparisons indicated that the neomycin-only group had 25% OHC loss while the neomycin plus noise 
group averaged 100% OHC loss.  Brown et al. (1978) also pointed out that IHC loss for the neomycin-
only group was minimal while the neomycin plus noise group neared 100% IHC loss. 
Influence of OHC Pathology on High-Level AEPs 
 Determining the influence of OHC damage on the amplitude of CAPs evoked with high-level 
chirp stimuli was the focus of the second experiment of this study.  These data are novel since published 
studies that have measured CAPs after administration of ototoxic agents have focused on response 
threshold instead of response amplitudes.  For example, Szymanski et al. (1994) analyzed CAP (and 
ABR) thresholds following a 14-day period of subcutaneous gentamicin injections in one group of 
pigmented gerbils and another group of albino gerbils.  They found that CAP threshold shifts were most 
pronounced for high frequency stimuli and significantly larger for albino gerbils than for pigmented 
gerbils following gentamicin treatment.  This influence on threshold was anticipated since gentamicin is 
known to induce OHC pathology.  Data for CAP amplitude for suprathreshold stimuli were not reported. 
Dallos and Harris (1978) examined the characteristics of single-unit recordings from chinchilla 
with kanamycin-induced OHC damage.  The characteristics of post-stimulus time histograms (e.g., 
latency, spontaneous rate, and time pattern) for animals with OHC pathology did not show any significant 
change suggesting that IHCs with which the afferent neurons synapse were functioning normally.  
Frequency threshold curves (FTC) obtained for units within the region of the OHC lesion exhibited 
truncated tips consistent with an elevated discharge threshold at the units’ characteristic frequency.  The 
tail segments of the FTCs for units within regions of OHC damage were essentially equivalent to FTCs 
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for normal units suggesting that when the stimulus was sufficiently intense, IHCs triggered normal neural 
firing independent of OHC action. 
 Eggermont (1977) obtained CAP tuning curves from transtympanic recordings in human patients 
using toneburst stimuli and tone-on-tone masking techniques.  Tuning curves from patients with hearing 
loss were compared to tuning curves from normal hearing individuals.  Patients with hearing loss 
exhibited broad tuning without pronounced tips but the tail segments of their tuning curves were roughly 
equivalent to the tail segments of tuning curves in normal hearing individuals.  Eggermont (1977) 
commented that those patients with hearing loss classified as sensory (inferred from the presence of 
recruitment) had normal CAP amplitudes for high-level stimuli.  This observation suggests that high-level 
stimuli produce enough basilar membrane displacement to depolarize IHCs and trigger afferent nerve 
firing. 
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Figures and Tables 
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Fig. 1. Top panel: Schematic of an uncoiled cochlea illustrates the idea of using multiple bandwidths 
of high-pass noise to systematically limit the region of auditory nerve fibers that can contribute 
synchronously to CAPs evoked with high-level stimuli.  Bottom left panel: Normalized N1 amplitude 
would theoretically grow differently for a cochlea with missing auditory nerve fibers (dashed line) 
than for a normal cochlea (solid line).  Bottom right panel: Derivatives of the respective cumulative 
amplitude functions (CAFs) yield neural density functions (NDFs) that theoretically reveal the 
distribution of viable nerve fibers contributing to the CAP. 
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Fig. 2. Left panel: Digital waveform of gerbil-tailored chirp that rises in frequency and amplitude over a 
duration of 3.06 ms.  Middle panel: Instantaneous frequency of chirp stimulus is equivalent to the inverse of 
cochlear traveling wave delay in gerbil (estimated with gerbil CAP latency data from Earl and Chertoff, 
2010). Right panel: Acoustic spectrum of chirp stimulus shows relatively flat spectral energy between 1 and 
60 kHz, spanning nearly the entire range of gerbil hearing. 
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Fig. 3. Left panel: Representative unmasked and masked CAP waveforms from a normal-
hearing gerbil illustrate the trend of decreasing N1 amplitude and increasing N1 latency as the 
high-pass noise masker cutoff frequency decreases.  Right panel: Representative raw data for N1 
amplitude (filled circles, units on right ordinate) and N1 latency (open circles, units on left 
ordinate) for all 25 masking conditions.  Unmasked values represent the mean of four unmasked 
CAP recordings. 
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Fig. 4. Left panel: Normalized N1 amplitude data (filled circles) plotted as a function of distance 
from apex (converted from masker cutoff frequency with frequency-place map for gerbil from 
Müller, 1996).  The cumulative amplitude function (CAF), shown with thick line along with its 
corresponding coefficient of determination (R
2
), is obtained by fitting the data with a four-parameter 
(a, b, x0, y0) sigmoid function.  Right panel: The neural density function (NDF; thick line) is 
obtained by using the CAF parameters to solve the analytical derivative of the CAF (Equation 2) for 
distance from apex (x).  The peak location is given by parameter x0 and the bandwidth is defined as 
the distance spanned by the inner 2/3 of the area under the curve (calculated by multiplying peak 
density by 0.3413 and finding the difference between the corresponding distance values). 
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Fig. 5. Top panel: A representative CAP evoked with 2 kHz tonebursts at 60 
dB pSPL (top left) is nearly 10 times smaller in magnitude than a CAP 
evoked with chirps at the same level (top right).  Bottom panel: Comparison 
of unmasked N1 amplitudes illustrates that chirps at 60 dB pSPL produced the 
largest CAPs.  Even chirps as low as 30 dB pSPL generated CAPs that were 
larger in magnitude than 2 kHz tonebursts at 90 dB pSPL.  Error bars = 1 SD; 
n = 9 for each stimulus condition except for chirp at 30 dB pSPL where n = 4. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
56 
 
 
 
 
Fig. 6. Normalized N1 amplitude data (thin lines) for nine normal-hearing gerbils (Experiment 
1) with their corresponding mean CAFs (thick lines) show differences in slope and variability 
across stimulus type and level.  The data shown with a dashed line in the upper right panel was 
determined to be an outlier (initial masked amplitude was more than two SD above the mean of 
initial masked amplitude across all stimulus conditions) and was excluded from further 
analysis.  Mean coefficients of determination (R
2
) indicate that the four-parameter sigmoid 
function accounts for a large majority of the variance in the data. 
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Fig. 7. Individual NDFs (thin lines) and the corresponding mean NDFs (thick lines) for the nine 
normal-hearing gerbils (Experiment 1) illustrate the distribution of neural firing density for 
each stimulus type and level combination.  The individual NDF shown with the dashed line in 
the upper right panel represents the outlier that was described in Fig. 6. 
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Fig. 8. Comparison of the mean NDFs for chirps (solid lines) and 2 kHz tonebursts (dashed 
lines) at each stimulus level reveals differences between bandwidth and peak location.  See 
Table 1 for statistical analysis. 
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Fig. 9. Left panel: Cochlear microphonic (CM) data for the 10 gerbils in Experiment 2 indicate an exponential 
decrease in amplitude over a course of minutes following application of 200 µg of gentamicin to the round 
window niche.  The CM was evoked with 16 kHz tonebursts (10 ms in duration) at 80 dB pSPL.  Dose-
response curves for lower gentamicin doses (50 and 100 µg) are shown for comparison.  Right panel: Post-
gentamicin CAP threshold data show shifts ranging from 10 to 25 dB for chirps and a general trend of 
increasing threshold shifts for tonebursts as stimulus frequency increases. 
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Fig. 10. Top panels: N1 amplitude functions for 10 gentamicin-exposed gerbils (thin lines) fall within the 
normal range (mean +/- 2SD; gray areas) for chirps at 90 dB pSPL, whereas for chirps at 60 dB pSPL, 6 
out of the 10 gentamicin-exposed animals fall outside the normal range. Thick dashed lines in the top 
panels represent the mean of the post-gentamicin CAFs.  Mean R
2
 values indicate that the four-parameter 
sigmoid function accounts for a large majority of the variance in the post-gentamicin data.  Bottom 
panels: Individual NDFs for the 10 gentamicin-exposed gerbils (thin lines) with the mean NDFs (thick 
dashed lines) plotted against the normal ranges (mean +/- 2SD; gray areas) indicate minimal difference 
between the mean bandwidth and mean peak location for chirps at 90 dB pSPL.  For chirps at 60 dB 
pSPL, mean bandwidth did not differ across groups but the mean peak location for the gentamicin-
exposed group was significantly more apical than the mean peak location for the normal-hearing group 
(open circle).  See Table 2 for statistical analysis. 
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Fig. 11.  Plotting the post-gentamicin shift in chirp CAP thresholds against the 
post-gentamicin shift in NDF peak location for chirps at 60 dB pSPL (re normal 
mean peak location for chirps at 60 dB pSPL) reveals a significant inverse 
correlation between the two variables.  Negative values for peak shift indicate 
apical shifts re normal peak location.  Filled circles (n = 10) represent the 
animals that met the inclusion criteria for Experiment 2.  Open circles (n = 4) 
represent animals excluded from analysis due to progressive CAP threshold 
shifts during the course of data collection (two upper circles) or due to minimal 
chirp CAP threshold shifts following gentamicin application (two lower circles). 
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Table 1. Descriptive statistics and results of paired samples t-tests comparing NDF 
bandwidth and peak location across stimulus type at 90 and 60 dB pSPL (Experiment 1)  
 
  Bandwidth (mm)   Peak location (mm) 
Mean SD† p  Mean SD† p 
Chirp 90 (n=8)* 4.87  
1.84 
 
0.04 
 8.22  
1.01 
 
 0.001 
Toneburst 90 (n=8)* 3.25  6.38 
Chirp 60 (n=9) 2.78  
2.04 
 
0.04 
 6.28  
0.61 
 
<0.001 
Toneburst 60 (n=9) 4.43  4.91 
 
*Sample size (n) reduced to 8 for paired comparisons at 90 dB pSPL due to exclusion of outlier 
indicated with dashed line in upper right panel of Fig. 6 
†SD, standard deviation of the paired differences 
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Table 2. Descriptive statistics and results of independent samples t-tests comparing bandwidth and peak 
location of chirp NDFs for normal vs. post-gentamicin groups at 90 and 60 dB pSPL (Experiment 2)  
 
   Bandwidth (mm)        Peak location (mm) 
  Mean SD p    Mean   SD p 
 
Chirp 90 
Normal (n=7)* 4.56 0.66  
0.64 
   8.43   0.79  
0.46 Post-gentamicin (n=10) 4.86 1.53    8.68   0.58 
 
Chirp 60 
Normal (n=9) 2.78 0.39  
0.24 
   6.28   0.17  
  0.01† Post-gentamicin (n=10) 3.05 0.54    5.55   0.72 
 
*Sample size (n) of normal group reduced to 7 for Chirp 90 NDFs due to exclusion of two outliers (initial masked 
amplitude > 2 SD above the mean initial masked amplitude of all chirp conditions)  
†Equal variances not assumed per Levene’s Test 
SD, standard deviation of the mean 
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Appendix C 
CAP Waveforms 
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Fig. C.1. Representative masked and unmasked CAP waveforms evoked with chirps at 90 dB pSPL from a 
normal-hearing gerbil.  High-pass (HP) masker cutoff frequencies are listed to the left of each waveform. 
 
Normal CAPs: Chirp – 90 dB pSPL 
 
 
 
 
250 µV 
15 ms 
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Fig. C.2. Representative masked and unmasked CAP waveforms evoked with chirps at 60 dB pSPL from a 
normal-hearing gerbil.  High-pass (HP) masker cutoff frequencies are listed to the left of each waveform. 
 
 
Normal CAPs: Chirp – 60 dB pSPL 
 
 
 
 
250 µV 
15 ms 
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Fig. C.3. Representative masked and unmasked CAP waveforms evoked with 2 kHz tonebursts at 90 dB 
pSPL from a normal-hearing gerbil.  High-pass (HP) masker cutoff frequencies are listed to the left of each 
waveform. 
 
 
Normal CAPs: 2 kHz Toneburst – 90 dB pSPL 
 
 
 
100 µV 
15 ms 
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Fig. C.4. Representative masked and unmasked CAP waveforms evoked with 2 kHz tonebursts at 60 dB 
pSPL from a normal-hearing gerbil.  High-pass (HP) masker cutoff frequencies are listed to the left of each 
waveform. 
 
 
 
Normal CAPs: 2 kHz Toneburst – 60 dB pSPL 
 
 
30 µV 
15 ms 
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Fig. C.5. Representative masked and unmasked CAP waveforms evoked with chirps at 90 dB pSPL from a 
gentamicin-exposed gerbil.  High-pass (HP) masker cutoff frequencies are listed to the left of each 
waveform.    
 
 
Post-gentamicin CAPs: Chirp – 90 dB pSPL 
 
 
100 µV 
15 ms 
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Fig. C.6. Representative masked and unmasked CAP waveforms evoked with chirps at 60 dB pSPL from a 
gentamicin-exposed gerbil.  High-pass (HP) masker cutoff frequencies are listed to the left of each 
waveform. 
 
 
 
Post-gentamicin CAPs: Chirp – 60 dB pSPL 
 
 
100 µV 
15 ms 
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Appendix D 
Latency Analysis 
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Fig. D.1. N1 latency shift (masked-unmasked latency) plotted as a function of high-
pass noise cutoff frequency for the normal-hearing group of Experiment 1.  
Individual animal data are shown with thin lines and the group means are shown with 
thick lines.  The latency shift functions are generally consistent with the theory 
suggested by Teas et al. (1962) and the data from others (e.g. Elberling, 1974, Don et 
al., 1979, Evans and Elberling, 1982) that the location of synchronous neural firing 
for moderate and high-level stimuli is “pushed” toward the apex proportional to the 
high-pass noise cutoff frequency.  The trends in latency shift resemble the inverse of 
the patterns observed for N1 amplitude growth (Fig. 6). 
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Fig. D.2. N1 latency shift (masked-unmasked latency) 
plotted as a function of high-pass noise cutoff frequency 
for the post-gentamicin group in Experiment 2 (thin lines = 
individual animal data; thick dashed lines = group means) 
indicates smaller shifts in latency and more variability 
when compared to the trends in the latency data from the 
normal-hearing group (Fig. D.1.). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
74 
 
 
 
 
 
 
 
 
 
 
 
Appendix E 
Alternative Analysis Method 
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Figure E.1. An alternative method for constructing NDFs by calculating the numerical derivatives of 
the N1 amplitude data (instead of taking the analytical derivative of the equation fitted to the data) 
preserves the “fine-structure” of neural firing density that may be useful for differentiation of normal 
and pathologic cochleae.  The top panels show the mean numerical NDFs for the normal-hearing 
group in Experiment 1 and the bottom panels show the mean numerical NDFs for the normal-
hearing and post-gentamicin groups compared in Experiment 2.  Statistical analyses of the numerical 
NDFs were not completed for this study; although a visual examination of the plots above suggest 
that the numerical NDFs also support the hypotheses that high-level chirps trigger a broader spread 
of neural firing than high-level 2 kHz tonebursts and that OHC pathology does not significantly alter 
high-level NDFs. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
